Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Deoxyribonuclease, antibody

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 86215 refers to a laboratory test that measures the presence of deoxyribonuclease (DNase) antibodies in the blood. DNase antibodies are specific enzymes that are produced by certain strains of beta-hemolytic streptococcus, a type of bacteria known to cause various infections. This blood test is particularly useful in the context of diagnosing streptococcal infections, especially when traditional tests such as antistreptolysin O (ASO) titers do not show elevated levels. It is important to note that DNase antibodies tend to rise more slowly compared to ASO antibodies and can remain elevated for a longer duration, making this test valuable in specific clinical scenarios. For instance, it may assist in diagnosing conditions such as Sydenham's chorea, which is a neurological disorder associated with rheumatic fever, post-streptococcal rheumatic fever itself, or glomerulonephritis, which is an inflammation of the kidney. The test is performed by obtaining a blood sample through a procedure known as venipuncture, which is separately reportable. The serum obtained from the blood sample is then analyzed using a technique called quantitative nephelometry, which allows for the precise measurement of the DNase antibody levels in the serum.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The CPT® Code 86215 is indicated for use in specific clinical situations where the presence of deoxyribonuclease (DNase) antibodies may aid in diagnosis. The following conditions are explicitly mentioned as indications for this test:

  • Streptococcal Infections - The test is performed when there is a suspicion of streptococcal infections, particularly when antistreptolysin O (ASO) titers are not elevated.
  • Sydenham's Chorea - This neurological disorder, which can occur following a streptococcal infection, may be diagnosed with the help of DNase antibody testing.
  • Post-Streptococcal Rheumatic Fever - The test can assist in diagnosing rheumatic fever that follows a streptococcal infection.
  • Glomerulonephritis - The presence of DNase antibodies may be relevant in the diagnosis of this kidney condition associated with streptococcal infections.

2. Procedure

The procedure for obtaining the results of CPT® Code 86215 involves several key steps that ensure accurate measurement of DNase antibody levels. The following procedural steps are outlined:

  • Step 1: Venipuncture - A qualified healthcare professional performs a venipuncture to collect a blood sample from the patient. This step is crucial as it provides the serum needed for testing. The venipuncture is a separate reportable procedure, and care is taken to ensure that the blood is drawn in a sterile manner to prevent contamination.
  • Step 2: Serum Separation - After the blood sample is collected, it is processed to separate the serum from the cellular components. This is typically done by allowing the blood to clot and then centrifuging it, which separates the serum for further analysis.
  • Step 3: Quantitative Nephelometry - The serum is then subjected to quantitative nephelometry, a laboratory technique that measures the concentration of DNase antibodies. This method involves passing a beam of light through the serum sample and measuring the amount of light scattered by the antibodies present, allowing for precise quantification of the DNase antibody levels.

3. Post-Procedure

After the procedure for CPT® Code 86215, the patient may be advised on standard post-venipuncture care, which includes applying pressure to the puncture site to minimize bleeding and potentially applying a bandage. There are typically no specific post-procedure restrictions, and patients can resume normal activities unless otherwise directed by their healthcare provider. The results of the DNase antibody test will be interpreted by the physician in conjunction with clinical findings and other laboratory results to make an accurate diagnosis.

Short Descr DEOXYRIBONUCLEASE ANTIBODY
Medium Descr DEOXYRIBONUCLEASE ANTIBODY
Long Descr Deoxyribonuclease, antibody
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 235 - Other Laboratory
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
GY Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit
Q4 Service for ordering/referring physician qualifies as a service exemption
Date
Action
Notes
2011-01-01 Changed Short description changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"